Diamondoids as molecular building blocks for nanotechnology

Topics in Applied Physics

Volumn 109, Issue , 2007, Pages 44-71

  Ramezani, Hamid ^a   Mansoori, G Ali ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548714647     PISSN: 03034216     EISSN: 14370859     Source Type: Book Series    
DOI: 10.1007/978-0-387-39938-6_4     Document Type: Article

References (72)

1. Mansoori, G.A.: Advances in atomic & molecular nanotechnology. In Nanotechnology: The Emerging Cutting-Edge Technology; Sep-Oct 2002. United Nations Tech Monitor; 2002: 53-59.
2. Siegel, R.W., Hu, E., Roco, M.C.: Nanostructure Sci. and Technology - A Worldwide Study. Prepared under the guidance of the IWGN, NSTC. WTEC, Loyola College in Maryland; 1999.
3. La Van, D.A., McGuire, T., Langer, R.: Small-scale systems for in vivo drug delivery. Nature Biotechnol 2003, 21:1184-1191.
4. Merkle, R.C.: Biotechnology as a route to nanotechnology. Trends Biotechnol 1999, 17:271-274.
5. Merkle, R.C: Nanotechnology 2000, 11:89.
6. Molecular building blocks and development strategies for molecular nanotechnology [http://www.zyvex.com/nanotech/mbb/mbb.html]
7. Drexler, K.E.: Building molecular machine systems. Trends Biotechnol 1999, 17: 5-7.
8. Bogunia-Kubik, K. and Sugisaka, M.: From molecular biology to nanotechnology and nanomedicine. Biosystems 2002, 65:123-138.
9. Freitas, R.A.: Respirocytes: High performance artificial nanotechnology red blood cell. Nanotechnol 1996, 2:8-13.
10. Freitas, R.A., Jr.: Exploratory design in medical nanotechnology: a mechanical artificial red cell. Artifficial Cells, Blood Substitutes Biotechnol 1998, 26:411-430.
11. Mansoori, G.A.: Principles of Nanotechnology: Molecular-Based Study of Condensed Matter in Small Systems. World Scientific, Singapore; 2005.
12. Dahl, J.E., Liu, S.G., and Carlson, R.M.: Isolation and structure of higher diamondoids, nanometer-sized diamond molecules. Science 2003, 299:96-99.
13. Vazquez Gurrola, D., Excobedo, J., and Mansoori, G.A.: Characterization of crude oils from southern Mexican oilfields. In Proceedings of the EXITEP 98, International Petroleum Technology Exhibition, Placio de Los Deportes; 15th-18th November 1998; Mexico City, Mexico, D.F.; 1998.
14. Rollmann, L.D., Green, L.A., Bradway, R.A., and Timken, H.K.C.: Adamantanes from petroleum with zeolites. Catalysis Today 1996, 31:163-169.
15. Kabo, G.J., Blokhin, A.V., Charapennikau, M.B., Kabo, A.G., and Sevruk, V.M.: Thermodynamic properties of adamantane and the energy states of molecules in plastic crystals for some cage hydrocarbons. Thermochim Acta 2000, 345:125-133.
16. Vazquez, D. and Mansoori, G.A.: Identification and measurement, of petroleum precipitates. J Petroleum Sci Eng 2000, 26:49-55.
17. Mansoori, G.A.: Modeling of asphaltene and other heavy organic depositions. J Petroleum Sci Eng 1997, 17:101-111.
18. Mansoori, G.A., Assoufid, L., George, T.R, and Zhang, G.: Measurement, simulation and prediction of intermolecular interactions and structural, characterization of organic nanostructures. In Proceedings of the Conference on Nanodevices and Systems, Nanotech 2003; February 23-27; San Francisco. 2003
19. Desiraju, G.R.: The supramolecular concept as a bridge between organic, inorganic and organometallic crystal chemistry. J Mol Structure 1996, 374:191-198.
20. Reiser, J., McGregor, E., Jones, J., Enick, R., and Holder, G.: Adamantane and diamantane; phase diagrams, solubilities, and rates of dissolution. Fluid Phase Equilibria 1996, 117:160-167.
21. Navratilova, M. and Sporka, K.: Synthesis of adamantane on commercially available zeolitic catalysts. Appl Catalysis A: Gen 2000, 203:127-132.
22. Mckervey, M.A.: Synthetic approaches to large diamondoid hydrocarbons. Tetrahedron 1980, 36:971-992.
23. Hopf, H.: Classics in Hydrocarbon Chemistry: Syntheses, Concepts, Perspectives. Weinheim: Wiley-VCH, 2000.
24. Shibuya, M., Taniguchi, T., Takahashi, M., and Ogasawara, K.: Chiral modification of adamantane. Tetrahedron Lett 2002, 43:4145-4147.
25. Zones, S.I., Nakagawa, Y., Lee, G.S., Chen, C.Y., and Yuen, L.T.: Searching for new high silica zeolites through a synergy of organic templates and novel inorganic conditions. Micropor Mesopor Mater 1998, 21:199-211.
26. Meador, M.A.: Annu Rev Mater Sci 1998, 28:599.
27. Hardman, J.G. and Limbird, L.E.: Goodman & Gilman's The pharmacological basis of Therapeutics. 10th edition. New York: McGraw-Hill, 2001.
28. Kazimierczuk, Z., Gorska, A., Switaj, T., and. Lasek, W.: Adamantylaminopyrimidines and -pyridines are potent inducers of tumor necrosis factor-α J. Bioorganic Medicinal Chem Lett 2001, 11:1197-1200.
29. Yaw-Terng, C. and Jane-Jen, W.: Synthesis of 1,6-Diaminodiamantane. Tetrahedron Lett 1995, 36:5805-5806.
30. Stamatiou, G., Kolocouris, A., Kolocouris, N., Fytas, G., Foscolos, G.B., Neyts, J., and De Clercq, E.: Novel 3-(2-Adamantyl)pyrrolidines with potent activity against influenza A virus-identification of aminoadamantane derivatives bearing two pharmacophoric amine groups. Bioorganic Medicinal Chem Lett 2001, 11:2137-2142.
31. Samoilova, M.V., Buldakova, S.L., Vorobjev, V.S., Sharonova, I.N., and Magazanik, L.G.: The open channel blocking drug, IEM-1460, reveals functionally distinct α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors in rat brain neurons. Neuroscience 1999, 94:261-268.
32. Bolshakov, K.V., Tikhonov, D.B., Gmiro, V.E., and Magazanik, L.G.: Different arrangement of hydrophobic and nucleophilic components of channel binding sites in N-methyl-d-aspartate and AMPA receptors of rat brain, is revealed by channel blockade. Neurosci Lett 2000, 291:101-104.
33. Buldakova, S.L., Vorobjev, V.S., Sharonova, I.N., Samoilova, M.V., and Magazanik, L.G.: Characterization of AMPA receptor populations in rat brain cells by the use of subunit-specific open channel, blocking drug, IEM-1460. Brain Res 1999, 846:52-58.
34. Rammes, G., Rupprecht, R., Ferrari, U., Zieglgänsberger, W., Parsons, C.G.: The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell, systems in a non-competitive manner. Neuroscience Lett 2001, 306:81-84.
35. Flynn, D.L., Becker, D.P., Spangler, D.P., Nosal, R., Gullikson, G.W., Moummi, C., and Yang, D.-C.: New aza(nor)adamantanes are agonists at the newly identified serotonin 5-HT4 receptor and antagonists at the 5-HT3 receptor. Bioorganic Medicinal Chem Lett 1992, 2:1613-1618.
36. Baxter, A., Bent, J., Bowers, K., Braddock, M., Brough, S., Fagura, M., Lawson, M., McInally, T., Mortimore, M., and Robertson, M.: Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists. Bioorganic Medicinal Chem Lett 2003, 13:4047-4050.
37. Zoidis, G., Papanastasiou, I., Dotsikas, I., Sandoval, A., Dos Santos, R.G., Papadopoulou-Daifoti, Z., Vamvakides, A., Kolocouris, N., and Felix, R.: The novel. GABA adamantane derivative (AdGABA): design, synthesis, and activity relationship with gabapentin. Bioorganic Medicinal Chem 2005, 13:2791-2798.
38. Shen, C., Bullens, D., Kasran, A., Maerten, P., Boon, L., Aerts, J.M.F.G., van Assche, G., Geboes, K., Rutgeerts, P., and Ceuppens, J.L.: Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)- deoxynojirimycin protects against the inflammatory response in hapten-induced colitis. Int Immunopharmacol 2004, 4:939-951.
39. Reissmann, S., Pineda, F., Vietinghoff, G., Werner, H., Gera, L., Stewart, J.M., and Paegelow, I.: Structure activity relationships for bradykinin antagonists on the inhibition of cytokine release and the release of histamine. Peptides 2000, 21:527-533.
40. Hoekstra, W.J., Press, J.B., Bonner, M.P., Andrade-Gordon, P., Keane, P.M., Durkin, K.A., Liotta, D.C., and Mayo, K.H.: Adamantane and Nipecotic Acid Derivatives as Novel [beta]-Turn Mimics. Bioorganic Medicinal Chem Lett 1994, 4:1361-1364.
41. Mathias, L.J. and Tullos, G.L.: Synthesis of adamantyl and benzoxazole substituted poly(m-phenylene)s via the nickel catalysed coupling of aryl chlorides. Polymer 1996, 37:3771-3774.
42. Chern, Y-T. and Wang, W.-L.: Synthesis and characterization of tough polyamides derived from 4,9-bis[4-(4-aminophenoxy)phenyl]diamantane. Polymer 1998, 39: 5501-5506.
43. Chem, Y.-T.: Synthesis of polyamides derived from 4,9-bis(4-aminophenyl) diamantane. Polymer 1998, 39:4123-4127.
44. Huang, C.-F., Lee, H.-F., Kuo, S.-W., Xu, H., and Chang, F.-C.: Star polymers via atom transfer radical polymerization from adamantane-based cores. Polymer 2004, 45:2261-2269.
45. Eastmond, G.C., Gibas, M., and Paprotny, J.: Pendant adamantyl poly(ether imide)s: synthesis and a preliminary study of properties. Euro Polym J1999,35:2097-2106.
46. Lee, Y.K., Jeong, H.Y., Kim, K.M., Kim, J.C., Choi, H.Y, Kwon, Y.D., Choo, D.J., Jang, Y.R., Yoo, K.H., Jang, J., and Talaie, A.: Synthesis of new PPV based polymer and its application to display. Curr Appl Phys 2002, 2:241-244.
47. Jeong, H.Y., Lee, Y.K., Talaie, A., Kim, K.M., Kwon, Y.D., Jang, Y.R., Yoo, K.H., Choo, D.J., and Jang, J.: Synthesis and characterization of the first adamantane-based poly(p-phenylenevinylene) derivative: an intelligent plastic for smart electronic displays. Thin Solid Films 2002, 417:171-174.
48. Kar, A.K. and Lightner, D.A.: Circular dichroism of distorted helices. C(10)-Adamantyl and C(10)-tert-butyl biliverdins. Tetrahedron: Asymmetry 1998, 9:3863-3880.
49. Seidl, P.R. and Leal, K.Z.: Steric contributions to carbon-13 chemical shifts of 1- and 2-methyl adamantanes by DFT/GIAO. J MoI Structure: THEOCHEM 2001, 539:159-162.
50. Martin, V.V., Alferiev, L.S., Weis, A.L.: Amplified fluorescent molecular probes based on 1,3,5,7-tetrasubstituted adamantane. Tetrahedron Lett 1999, 40:223-226.
51. Tsuzuki, N., Hama, T., Kawada, M., Hasui, A., Konishi, R., Shiwa, S., Ochi, Y., Futaki, S., and Kitagawa, K.: Adamantane as a brain-directed drug carrier for poorly absorbed drug. 2. AZT derivatives conjugated with the 1-adamantane moiety. J Pharmaceut Sci 1994, 83:481-484.
52. Tsuzuki, N., Hama, T., Hibi, T., Konishi, R., Futaki, S., and Kitagawa, K.: Adamantane as a brain-directed drug carrier for poorly absorbed drug: Antinociceptive effects of [D-Ala2]Leu-enkephalin derivatives conjugated with the 1-adamantane moiety. Biochem Pharmacol 1991, 41:R5-8.
53. Kitagawa, K., Mizobuchi, N., Hama, T., Hibi, T., Konishi, R., and Futaki, S.: Synthesis and antinociceptive activity of [D-Ala2]Leu-enkephalin derivatives conjugated with the adamantane moiety. Chem Pharmaceut Bull (Tokyo) 1997, 45:1782-1787.
54. Manoharan, M., Tivel, K.L., and Cook, P.D.: Lipidie nucleic acids. Tetrahedron Lett 1995, 36:3651-3654.
55. Lomadze, N. and Schneider, H.-J.: Reversal of polyamine selectivity for DNA and RNA by steric hindrance. Tetrahedron Lett 2002, 43:4403-4405.
56. Moine, L., Cammas, S., Amiel, C., Guerin, P., and Sebille, B.: Polymers of malic acid conjugated with the 1-adamantyl moiety as lipophilic pendant, group. Polymer 1997, 38:3121-3127.
57. Ranganathan, D. and Kurur, S.: Synthesis of totally chiral, multiple armed, poly glu and poly asp scaffoldings on bifunctional adamantane core. Tetrahedron Lett 1997, 38:1265-1268.
58. Busch, K. and Tampé, R.: Single molecule research on surfaces: from analytics to construction and back. Rev Mol Biotechnol 2001, 82:3-24.
59. Kim, J.H., Hong, J.-A., Yoon, M., Yoon, M.Y., Jeong, H.-S., and Hwang, H.J.: Solid-phase genetic engineering with DNA immobilized on. a gold surface. J Biotechnol 2002, 96:213-221.
60. Nanotechnology in medicine [http://www.foresight.org/Updates/Update16/ Update16.1.html#anchor576239]
61. Shokova, E., Tafeenko, V., and Kovalev, V.: First synthesis of adamantylated thiacalix[4]arenes. Tetrahedron Lett 2002, 43:5153-5156.
62. Ranganathan, D., Samant, M.P., Nagaraj, R., and Bikshapathy, E.: Design, synthesis and membrane ion transport properties of cystine- and serine-based cyclo-4-oxa-heptane-1, 7-bisamides. Tetrahedron Lett 2002, 43:5145-5147.
63. Ranganathan, D., Haridas, V., and Karle, I.L.: Diamond crowns: Design, synthesis and x-ray crystallographic studies of a novel family of adamantane-containing crown ethers. Tetrahedron 1999, 55:6643-6656.
64. Ranganathan, D., Thomas, A., Haridas, V., Kurur, S., Madhusudanan, K.P., Roy, R., Kunwar, A.C., Sarma, A.V., Vairamani, M., and Sarma, K.D.: Design, synthesis, and characterization of tyrosinophanes, a novel family of aromatic-bridged tyrosine-based cyclodepsipeptides. J Organic Chem 1999, 64:3620-3629.
65. Ranganathan, D., Haridas, V., Kurur, S., Nagaraj, R., Bikshapathy, E., Kunwar, A.C., Sarma, A.V., and Vairamani, M.: Norbornene-constrained cyclic peptides with hairpin architecture: design, synthesis, conformation, and membrane ion transport. J Organic Chem 2000, 65:365-374.
66. Ranganathan, D., Haridas, V., Nagaraj, R., and Karle, I.L.: Doublehelical cyclic peptides: design, synthesis, and crystal, structure of figure-eight mirror-image conformera of adamantane-constrained cystine-containing cyclic peptide cyclo (Adm-Cyst)(3). J Organic Chem 2000, 65:4415-4422.
67. Karle, I.L.: Hydrogen, bonds in molecular assemblies of natural, synthetic and 'designer' peptides. J Mol Structure 1999, 474:103-112.
68. Karle, I. and. Ranganathan, D.: Construction of polar and. hydrophobic pores and channels by assembly of peptide molecules. J Mol Structure 2003, 647:85-96.
69. Jaime, C., Redondo, J., Sanchez-Ferrando, F., and Virgili, A.: [beta]-cyclodextrin inclusion complex with adamantane Intermolecular 1H{1H} NOE determinations and molecular mechanics calculations. J Mol Structure 1991, 248:317-329.
70. Karakasyan, C., Millot, M.-C., and Vidal-Madjar, C.: Immobilization of a (dextran-adamantane-COOH) polymer onto [beta]-cyclodextrin-modified silica. J Chromatography B 2004, 808:63-67.
71. Ayres, P.D., Khan, S.I., and Chapman, O.L.: Synthesis and x-ray crystal, structures of poly-adamantane molecular rods. Tetrahedron Lett 1994, 35:8561-8564.
72. Ishizone, T., Tajima, H., Matsuoka, S., and Nakahama, S.: Synthesis of tetramers of 1,3-adamantane derivatives. Tetrahedron Lett 2001, 42:8645-8647.